German industrial conglomerate Siemens saw revenue after currency adjustments grow 5% in its Siemens Healthcare division for its fiscal third quarter, while operating profit and margin were also helped by the weakness of the euro against the U.S. dollar.
For the period (end-June 30), Siemens Healthcare reported Q3 revenues of $3.545 billion (3.246 billion euros), compared with revenues of $3.045 billion (2.788 billion euros) after currency adjustments in the corresponding period of fiscal 2014, representing growth of 16% on an actual basis and 5% after currency adjustments. The company reported an operating profit of $600 million (549 million euros) in the most recent period, up 23% from a profit of $486.1 million (445 million euros) in the same period the year before.
Orders in the healthcare unit also grew in the third quarter, hitting $3.625 billion (3.318 billion euros), compared with $3.165 (2.897 billion euros) on a currency-adjusted basis in the third quarter of 2014. This represented growth of 15% on an actual basis and 4% after currency adjustments.
Orders and revenues were up in all healthcare segments, led strongly by the firm's imaging and therapy systems, Siemens reported. On a regional basis, all regions contributed to the growth except for orders in the Asia/Australia region, which included a large order in China in the third quarter of 2014.
